Loading…

Balchem CorpBCPCCompetitor analysis, valuation and peers

United States · USD·Consumer Staples›Food: Specialty/Candy

Makes specialty ingredients: choline nutrients for animal feed, encapsulated nutrients for food, and performance/industrial chemicals.

Momentum neutral 54
Mkt cap
$5.36B
US dollars, full cap
Free float
99%
of shares outstanding
$/day
$50.8M
20-day average traded
Fwd P/E
29.9×
forward earnings
ROIC−WACC
+4.2 pp
WACC 9.2%
Hurdle
+6 pp
Req g minus delivered
Next earnings
93 days
19 Feb 2027
Close · USD$168.73
1D-0.5%
1W-2.6%
1M-1.7%
3M-6.1%
6M+4.7%
YTD+10.0%
1Y+8.5%
ATR %2.3%
Beta0.20
52w lowhigh9.4% off high

What Balchem does

Makes specialty ingredients: choline nutrients for animal feed, encapsulated nutrients for food, and performance/industrial chemicals.

Sells ingredients that customers blend into feed, foods and supplements, including choline protected to survive a cow's stomach, which helps dairy herd health. An ethylene oxide unit sells sterilisation gas and other specialty chemicals to healthcare and industrial users. Growth is helped by buying small niche ingredient companies.

Products and services

  • Animal nutrition & health (choline)
  • Human nutrition & health (encapsulated ingredients)
  • Performance products (specialty gases/chemicals)

Customers

  • Animal feed producers
  • Food & supplement manufacturers
  • Industrial customers

Where it sits in the supply chain

  • Specialty ingredients
  • Nutrient & specialty chemical…
  • Supply to animal feed/food/industrial…

What could go right

  • Animal/human nutrition ingredient demand growth
  • Bolt-on acquisitions in specialty nutrition

What could go wrong

  • Raw material cost swings
  • Niche-market customer concentration

Moat: narrow (IP / patents, process know-how, customer qualification). Encapsulation and specialty-chemical process know-how create qualification barriers for niche nutrient markets.

Headquarters: New Hampton, New York, US · Founded: 1967 · Employees: 1,352

Named competitors

Balchem at a glance

Size Balchem (BCPC) is a United States Consumer Staples company (Food: Specialty/Candy) with a market value of $5.36B, the 1123rd largest of 3,085 United States companies the cockpit tracks. Shares closed at $168.73 on 18 Nov 2026.

Performance Over six months the shares gained 4.7%, against +3.6% for the median peer and -2.2% for the United States market (cap-weighted) — 10th highest of 21 in its peer set.

Growth Revenue grew 9.4% over the last twelve months (peer median +6.5%); the operating margin is 21.5% (peer median 9.6%).

Valuation It trades at 29.9× forward earnings against a peer median of 17.6× (3rd most expensive of 21).

Price implies For today's price to make sense, revenue must grow about 14% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 4.2 points above its cost of capital (9.2% WACC).

Short interest Short interest is 1.6% of the free float (30 Oct 2026).

Next results Next results expected around 19 Feb 2027 (exchange calendar; dates can move).

Relative performance

10010511021 May 202621 Aug 202618 Nov 2026BCPC 104Peer median 103
Six months, rebased to 100: Balchem against the median of its 20 peers (local-currency closes).

Balchem financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.11B$1.04B$954M$922M$942M
Revenue growth—+9%+3%-2%—
Gross profit$404M$371M$336M$302M$280M
EBITDA$287M$264M$232M$233M$199M
Net income$171M$155M$128M$109M$105M
Free cash flow$178M$173M$146M$146M$88.2M
Capital expenditure$45.8M$43.5M$35.7M$37.9M$50.3M
Total debt$142M$181M$208M$330M$461M

Quarterly statements and history in the cockpit →

Balchem competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%-10%0%+10%28972212INGRSXT600298AAK2875603345LWCPBCOCOBARNDAR2269POST271560ASH605589TATEFRPTBCPC6-month return →1-month return →
Up and to the right = strong over both horizons. Balchem is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%10×20×30×28972212INGRSXT600298AAK2875603345LWCPBCOCOBARNDAR2269POST271560605589TATEFRPTBCPCRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Balchem is the large dot.

Capital: growth delivered against growth the price implies

0%+20%0%20%28972212INGR600298AAK603345LWCOCOBARN271560ASHTATEFRPTBCPCGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Balchem is the large dot.

Balchem competitors and peer comparison

Head to head with its named competitors (BCPC vs ADM vs DSFIR.AS vs IFF)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Balchem BCPC$5.36B+5%+9%22%29.9×14.3%
Archer Daniels Midland ADM$32.3B-13%+1%3%11.7×7.9%
DSM-Firmenich DSFIR.AS$27.5B+47%-45%8%28.6×23.7%
International Flavors & Fragrances IFF$20.1B+8%-17%11%22.7×17.9%
Phibro Animal Health PAHC$1.44B+5%+10%13%9.9×-6.4%
Bluestar Adisseo 600299.SS$3.70B-34%+15%13%11.3×-9.4%

How Balchem compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Balchem against its 20 peers (data as of 18 Nov 2026)
MeasureBCPCPeer medianRank in peer set
1-month return-1.7%+2.2%7th lowest of 21
6-month return+4.7%+3.6%10th highest of 21
Distance from 52-week high-9.4%-18.7%4th highest of 21
Revenue growth (TTM)+9.4%+6.5%9th highest of 21
Operating margin21.5%9.6%highest of 21
Forward P/E29.9×17.6×3rd most expensive of 21
Growth the price implies (Req g, 7 yrs)14.3%-1.5%2nd most demanding of 18
Growth delivered (Del g)+8.1%+10.5%6th lowest of 18
Hurdle (Req g minus delivered)+6.3 pp-8.6 pp2nd most demanding of 18
ROIC minus cost of capital+4.2 pp+2.3 pp6th highest of 21
EV / EBITDA18.9×10.0×2nd most expensive of 18
Net debt / EBITDA0.3×1.0×5th least indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Balchem BCPCUnited States$5.36B+5%+9%22%29.9×14.3%+8.1%
Nissin Foods 2897.TJapan$5.38B+10%+7%6%17.3×6.6%+9.3%
Yamazaki Baking 2212.TJapan$5.39B+35%+5%5%19.3×-2.6%+5.3%
Ingredion INGRUnited States$5.60B-11%-1%11%9.3×-5.6%+3.8%
Sensient Technologies SXTUnited States$5.00B+3%+10%15%24.6×n/an/a
Angel Yeast 600298.SSChina$5.00B+5%+15%11%19.7×4.3%+13.4%
Aak AAK.STSweden$4.48B-32%-1%10%13.0×-6.4%+10.5%
Toyo Suisan Kaisha 2875.TJapan$6.81B-1%+7%17%14.8×-4.3%+9.5%
Anjoy Foods 603345.SSChina$4.05B-8%+19%12%18.3×-2.9%+18.4%
Lamb Weston LWUnited States$7.20B+25%+3%10%15.7×3.9%+12.5%
Campbell's CPBUnited States$7.27B+22%-5%11%14.4×-2.5%+2.8%
Vita Coco COCOUnited States$3.86B-13%+26%20%32.7×10.1%+14.4%
Barry Callebaut BARN.SWSwitzerland$8.04B+4%-18%5%23.3×-7.1%+11.1%
Darling Ingredients DARUnited States$8.05B-12%+16%9%7.7×8.0%+11.4%
Meiji 2269.TJapan$8.08B+26%+3%8%19.1×n/an/a
Post POSTUnited States$3.55B-17%+6%10%11.6×-1.5%+7.4%
Orion 271560.KSSouth Korea$3.52B-20%+12%17%10.3×-15.6%+8.4%
Ashland ASHUnited States$3.50B+36%+2%7%18.0×12.7%-2.5%
Jinan Shengquan Group Share 605589.SSChina$3.30B-38%+12%8%20.2×n/an/a
Tate & Lyle TATE.LUnited Kingdom$3.27B+11%+2%8%15.8×13.2%+10.6%
Freshpet FRPTUnited States$3.27B+40%+12%9%37.5×30.2%+28.2%

Questions

Who are Balchem's main competitors?
Named competitors: Kemin Industries (private) (private or unlisted), ADM (nutrition) (ADM), DSM-Firmenich (DSFIR.AS), International Flavors & Fragrances (IFF), Kerry Group (private or unlisted), Phibro Animal Health (PAHC). The cockpit's measured peer set (industry) also includes Nissin Foods (2897.T), Yamazaki Baking (2212.T), Ingredion (INGR), Sensient Technologies (SXT), Angel Yeast (600298.SS), Aak (AAK.ST).
Is Balchem expensive compared with its peers?
On forward p/e it trades at 29.9× against a peer median of 17.6×, 3rd most expensive of 21 in its peer set. For today's price to make sense, revenue must grow about 14% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Balchem stock performed?
Over six months to 18 Nov 2026 the shares returned +4.7% against +3.6% for the median peer; over one year +8.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.